糖尿病并发结核病治疗中多学科合作应注意的问题

doi:10.3969/j.issn.1000-6621.2021.07.002

摘要/Abstract

摘要：

糖尿病与结核病都是当今世界严重的公共卫生问题,糖尿病并发结核病的治疗需要多学科合作,这种合作需要以患者为中心和坚持以科学证据为基础的原则。笔者就糖尿病并发结核病的治疗中多学科合作应注意的问题作一初步探讨,供同道参考并请指正

Abstract:

Both diabetes mellitus (DM) and tuberculosis (TB) are significant public health problem worldwide. Multi-sector approaches are recommended to treat patients with DM-TB. However, the multi-sector approaches should be patient-centered and supported with sufficient scientific evidences. This paper aimed to preliminary address issues in the multi-sector approaches during anti-TB treatment for patients with DM-TB. Views expressed in this paper are truly for discussion in the clinical practice.

Key words: Diabetes mellitus, Tuberculosis, Comorbidity, Multi-sector approach, Treatment and management

林岩, 邓国防. 糖尿病并发结核病治疗中多学科合作应注意的问题[J]. 中国防痨杂志, 2021, 43(7): 649-652. doi: 10.3969/j.issn.1000-6621.2021.07.002

LIN Yan, DENG Guo-fang. Issues that need attention in the multi-sector approaches on providing anti-tuberculosis treatment for patients with diabetes mellitus-tuberculosis[J]. Chinese Journal of Antituberculosis, 2021, 43(7): 649-652. doi: 10.3969/j.issn.1000-6621.2021.07.002

参考文献 31

[1]	International Diabetes Federation. IDF Diabetes Atlas ninth edition 2019. Brussels: International Diabetes Federation, 2019.
[2]	Al-Rifai RH, Pearson F, Critchley JA, et al. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One, 2017, 12(11):e0187967. doi: 10.1371/journal.pone.0187967. doi: 10.1371/journal.pone.0187967 URL
[3]	Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop Med Int Health, 2018, 23(10):1058-1070. doi: 10.1111/tmi.13133. doi: 10.1111/tmi.13133 URL
[4]	Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn, 2007, 3(3):228-245. doi: 10.1177/1742395307081502. doi: 10.1177/1742395307081502 URL
[5]	Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med, 2008, 5(7):e152. doi: 10.1371/journal.pmed.0050152. doi: 10.1371/journal.pmed.0050152 URL
[6]	Corris V, Unwin N, Critchley J. Quantifying the association between tuberculosis and diabetes in the US: a case-control analysis. Chronic Illn, 2012, 8(2):121-134. doi: 10.1177/1742395312440294. doi: 10.1177/1742395312440294 URL
[7]	Reed GW, Choi H, Lee SY, et al. Impact of diabetes and smoking on mortality in tuberculosis. PLoS One, 2013, 8(2):e58044. doi: 10.1371/journal.pone.0058044. doi: 10.1371/journal.pone.0058044 URL
[8]	Huangfu P, Ugarte-Gil C, Golub J, et al. The effects of diabetes on tuberculosis treatment outcomes: an updated syste-matic review and meta-analysis. Int J Tuberc Lung Dis, 2019, 23(7):783-796. doi: 10.5588/ijtld.18.0433. doi: 10.5588/ijtld.18.0433 URL
[9]	Leung CC, Yew WW, Mok TYW, et al. Effects of diabetes mellitus on the clinical presentation and treatment response in tuberculosis. Respirology, 2017, 22(6):1225-1232. doi: 10.1111/resp.13017. doi: 10.1111/resp.13017 pmid: 28244689
[10]	Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med, 2011, 9:81. doi: 10.1186/1741-7015-9-81. doi: 10.1186/1741-7015-9-81 URL
[11]	Liu Q, Li W, Xue M, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Sci Rep, 2017, 7(1):1090. doi: 10.1038/s41598-017-01213-5. doi: 10.1038/s41598-017-01213-5 URL
[12]	Golub JE, Mok Y, Hong S, et al. Diabetes mellitus and tuberculosis in Korean adults: impact on tuberculosis incidence, recurrence and mortality. Int J Tuberc Lung Dis, 2019, 23(4):507-513. doi: 10.5588/ijtld.18.0103. doi: 10.5588/ijtld.18.0103 URL
[13]	Harries AD, Kumar AM, Satyanarayana S, et al. Diabetes mellitus and tuberculosis: programmatic management issues. Int J Tuberc Lung Dis, 2015, 19(8):879-886. doi: 10.5588/ijtld.15.0069. doi: 10.5588/ijtld.15.0069 URL
[14]	Pan SC, Ku CC, Kao D, et al. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol, 2015, 3(5):323-330. doi: 10.1016/S2213-8587(15)00042-X. doi: 10.1016/S2213-8587(15)00042-X URL
[15]	Lin Y, Harries AD, Kumar AM, et al. Management of diabetes mellitus-tuberculosis: a guide to the essential practice[EB/OL].[2021-05-12]. https://www.theunion.org/what-we-do/publications/technical/english/TheUnion_DMTB_Guide.pdf.
[16]	Ma RCW. Epidemiology of diabetes and diabetic complications in China. Diabetologia, 2018, 61(6):1249-1260. doi: 10.1007/s00125-018-4557-7. doi: 10.1007/s00125-018-4557-7 URL
[17]	Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA, 2017, 317(24):2515-2523. doi: 10.1001/jama.2017.7596. doi: 10.1001/jama.2017.7596 URL
[18]	Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA, 2013, 310(9):948-958. doi: 10.1001/jama.2013.168118. doi: 10.1001/jama.2013.168118 URL
[19]	国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 国家代谢性疾病临床医学研究中心, 等. 结核病与糖尿病共病的治疗管理专家共识. 中国防痨杂志, 2021, 43(1):12-22. doi: 10.3969/j.issn.1000-6621.2021.01.004. doi: 10.3969/j.issn.1000-6621.2021.01.004
[20]	Crevel RV, Critchley JA. The Interaction of Diabetes and Tuberculosis: Translating Research to Policy and Practice. Trop Med Infect Dis, 2021, 6(1):8. doi: 10.3390/tropicalmed6010008. doi: 10.3390/tropicalmed6010008
[21]	Lin Y, Yuan Y, Zhao X, et al. The change in blood glucose levels in tuberculosis patients before and during anti-tuberculosis treatment in China. Glob Health Action, 2017, 10(1):1289737. doi: 10.1080/16549716.2017.1289737. doi: 10.1080/16549716.2017.1289737 URL
[22]	Harries AD, Kumar AM, Satyanarayana S, et al. Communicable and non-communicable diseases: connections, synergies and benefits of integrating care. Public Health Action, 2015, 5(3):156-157. doi: 10.5588/pha.15.0030. doi: 10.5588/pha.15.0030 pmid: 26393110
[23]	Magee MJ, Salindri AD, Gujral UP, et al. Convergence of non-communicable diseases and tuberculosis: a two-way street? Int J Tuberc Lung Dis, 2018, 22(11):1258-1268. doi: 10.5588/ijtld.18.0045. doi: 10.5588/ijtld.18.0045
[24]	Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, et al. Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med, 2016, 164(8):542-552. doi: 10.7326/M15-3016. doi: 10.7326/M15-3016
[25]	Standards of Medical Care in Diabetes-2017. Diabetes Care, 2017, 40(Suppl 1):S4-S5. doi: 10.2337/dc17-S003. doi: 10.2337/dc17-S003 URL
[26]	Qaseem A, Wilt TJ, Kansagara D, et al. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Gui-dance Statement Update From the American College of Physicians. Ann Intern Med, 2018, 168(8):569-576. doi: 10.7326/M17-0939. doi: 10.7326/M17-0939 pmid: 29507945
[27]	van Crevel R, Koesoemadinata R, Hill PC, et al. Clinical management of combined tuberculosis and diabetes. Int J Tuberc Lung Dis, 2018, 22(12):1404-1410. doi: 10.5588/ijtld.18.0340. doi: 10.5588/ijtld.18.0340
[28]	Dlodlo RA, Brigden G, Heldal E, et al. Management of tuberculosis: a guide to essential practice[EB/OL]. [2021-05-12]..
[29]	Lin Y, Harries AD. Tuberculosis infection control measures in diabetes clinics in China: a rapid assessment of 10 hospitals. Trop Med Int Health, 2015, 20(9):1196-1200. doi: 10.1111/tmi.12537. doi: 10.1111/tmi.12537 URL
[30]	Degner NR, Wang JY, Golub JE, et al. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment. Clin Infect Dis, 2018, 66(2):198-205. doi: 10.1093/cid/cix819. doi: 10.1093/cid/cix819 URL
[31]	Singhal A, Jie L, Kumar P, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med, 2014, 6(263): 263ra159. doi: 10.1126/scitranslmed.3009885. doi: 10.1126/scitranslmed.3009885 URL